116 related articles for article (PubMed ID: 9440548)
1. Simple diagnosis of graft-versus-host disease.
Hiraoka A; Kawakami M; Fukuda H; Nakamura H; Karasuno T; Teshima H; Masaoka T
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S70-2. PubMed ID: 9440548
[TBL] [Abstract][Full Text] [Related]
2. Marked increase of CD8+S6F1+ and CD8+CD57+ cells in patients with graft-versus-host disease after allogeneic bone marrow transplantation.
Fukuda H; Nakamura H; Tominaga N; Teshima H; Hiraoka A; Shibata H; Masaoka T
Bone Marrow Transplant; 1994 Feb; 13(2):181-5. PubMed ID: 7515741
[TBL] [Abstract][Full Text] [Related]
3. Impact of cytomegalovirus and grafts versus host disease on the dynamics of CD57+CD28-CD8+ T cells after bone marrow transplant.
Mendes AV; Kallas EG; Benard G; Pannuti CS; Menezes R; Dulley FL; Evans TG; Salomão R; Machado CM
Clinics (Sao Paulo); 2008 Oct; 63(5):667-76. PubMed ID: 18925328
[TBL] [Abstract][Full Text] [Related]
4. Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection.
Dolstra H; Preijers F; Van de Wiel-van Kemenade E; Schattenberg A; Galama J; de Witte T
Br J Haematol; 1995 Jun; 90(2):300-7. PubMed ID: 7540855
[TBL] [Abstract][Full Text] [Related]
5. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
[TBL] [Abstract][Full Text] [Related]
6. Peripheral blood lymphocyte subsets after allogeneic bone marrow transplantation: reconstitution and correlation with the occurrence of acute graft-versus-host disease.
Chan EY; Chiu EK; So MK; Lie AK; Chan TK
Asian Pac J Allergy Immunol; 1994 Dec; 12(2):117-23. PubMed ID: 7612104
[TBL] [Abstract][Full Text] [Related]
7. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
[TBL] [Abstract][Full Text] [Related]
8. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
[TBL] [Abstract][Full Text] [Related]
9. [Remarkable increase of CD8+ CD11a+ and CD8+ CD57- T cells in patients with post-transfusion graft-versus-host disease].
Karasuno T; Nakamura H; Fukuda H; Okajima Y; Maeda T; Teshima H; Hiraoka A; Masaoka T
Rinsho Ketsueki; 1998 Sep; 39(9):716-8. PubMed ID: 9796409
[TBL] [Abstract][Full Text] [Related]
10. The role of purified CD8+ T cells in graft-versus-leukemia activity and engraftment after allogeneic bone marrow transplantation.
Palathumpat V; Dejbakhsh-Jones S; Strober S
Transplantation; 1995 Aug; 60(4):355-61. PubMed ID: 7652765
[TBL] [Abstract][Full Text] [Related]
11. Transition of T cell receptor gamma/delta expressing double negative (CD4-/CD8-) lymphocytes after allogeneic bone marrow transplantation.
Yabe M; Yabe H; Hattori K; Hinohara T; Morimoto T; Kato S; Kusunoki A
Bone Marrow Transplant; 1994 Nov; 14(5):741-6. PubMed ID: 7889006
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
[TBL] [Abstract][Full Text] [Related]
13. Increased numbers of CD8+CD11+, CD8+CD11- and CD8+Leu7+ cells in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Yabe H; Yabe M; Kato S; Kimura M; Iwaki K
Bone Marrow Transplant; 1990 May; 5(5):295-300. PubMed ID: 1693537
[TBL] [Abstract][Full Text] [Related]
14. Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation.
Jansen J; Hanks S; Akard L; Martin M; Thompson J; Chang Q; Ash R; Garrett P; Figg F; English D
Bone Marrow Transplant; 1995 Feb; 15(2):271-8. PubMed ID: 7773217
[TBL] [Abstract][Full Text] [Related]
15. CD57+ T cells augment IFN-gamma production in a one-way mixed lymphocyte reaction and their expansion after stem cell transplantation in paediatric patients.
Koike Y; Seki S; Ohkawa T; Kaneko T; Kogawa K; Fujitsuka S; Hiraide H; Sekine I
Clin Exp Immunol; 2002 Oct; 130(1):162-8. PubMed ID: 12296868
[TBL] [Abstract][Full Text] [Related]
16. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
[TBL] [Abstract][Full Text] [Related]
17. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
[No Abstract] [Full Text] [Related]
18. Differences between lymphocyte subsets, after allogeneic bone marrow transplantation, in patients who received tacrolimus and patients who received cyclosporin A.
Fukuda H; Teshima H; Karasuno T; Hiraoka A; Nakamura H; Masaoka T
Int J Hematol; 2000 Jan; 71(1):70-4. PubMed ID: 10729997
[TBL] [Abstract][Full Text] [Related]
19. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
[TBL] [Abstract][Full Text] [Related]
20. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
